COVID 19 and diabetes: An endocrinologist's perspective

Area of Science:

• Internal Medicine
• Infectious Diseases
• Endocrinology

Background:

• COVID-19 clinical presentation ranges from mild to severe, impacting multiple organ systems.
• Advanced age and comorbidities (diabetes, hypertension, cerebrovascular history) are linked to poorer COVID-19 outcomes.
• Mechanisms linking COVID-19 to diabetes include chronic inflammation (cytokine storm) and direct pancreatic insult.

Purpose of the Study:

• To explore the multifaceted clinical manifestations of COVID-19.
• To investigate the association between COVID-19, advanced age, comorbidities, and patient outcomes.
• To discuss potential therapeutic strategies for COVID-19, particularly in relation to diabetes management and severe illness.

Main Methods:

• Literature review of clinical manifestations and outcomes of COVID-19.
• Analysis of risk factors contributing to severe COVID-19 and adverse outcomes.
• Review of emerging therapeutic options, including anti-interleukin antibodies.

Main Results:

• COVID-19 exhibits a wide spectrum of symptoms, from mild to critical.
• Older individuals and those with diabetes mellitus face increased risks for severe COVID-19.
• Cytokine storm and direct pancreatic effects are hypothesized to influence diabetes in COVID-19 patients.

Conclusions:

• Individualized, patient-centric treatment is crucial for managing COVID-19, especially in those with diabetes and other risk factors.
• Optimal blood sugar control is paramount for improving outcomes in diabetic COVID-19 patients.
• Anti-interleukin antibodies show promise as a therapeutic avenue for severe COVID-19.